A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Hidradenitis Suppurativa

In brief

A Randomized, Double-blinded, Placebo-controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Hidradenitis Suppurativa

Key facts

Study ID
NCT05348681
Run by
Aristea Therapeutics, Inc.
People needed
25
Starts
2022-07-18
Expected to finish
2023-02-28
Last updated by the study team
2023-06-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.